Maturation, pharmacogenomics and metabolomics as factors determining pharmacokinetic and pharmacodynamics profile of alpha-agonist in pediatric intensive care unit patients (J. Bartkowiak-Wieczorek, J. Mocarska, A. Bartkowska-Śniatkowska, J. Matysiak, A. Klupczyńska, Z. J. Kokot, P. Wiczling, E. Grześkowiak, & A. Bienert , Trans.). (2016). Journal of Medical Science, 85(3), 219-222. https://doi.org/10.20883/jms.2016.147